Struthers Richard Scott

CIK 00017462981 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001746298

Recent Transactions

50 trades

Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-12-18−16,342→ 0 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-12-18−28,400→ 259,058 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-12-18$9.28/sh+16,342→ 336,359 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-12-18$15.29/sh+28,400→ 364,759 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-09-26$45.00/sh−4,000→ 106,000 total
Gift
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-05-14+90,400→ 661,205 total
Gift
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-05-14−90,400→ 320,017 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-04-02$1.91/sh+81,270→ 410,417 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-04-02−81,270→ 0 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-03-19$34.17/sh−16,463→ 330,022 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-03-19$34.83/sh−875→ 329,147 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-02-20+89,000→ 346,485 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-02-20+313,000→ 313,000 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-12-02$57.57/sh−10,000→ 100,000 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-05-08$9.28/sh+107,448→ 364,933 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2024-05-08−107,448→ 16,342 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-05-08$49.40/sh−107,448→ 257,485 total
Gift
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-04-18−350→ 257,485 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2024-04-15−20,000→ 81,270 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-04-15$1.91/sh+20,000→ 257,835 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Non-qualified stock option (Right to Buy)
2024-04-04−40,951→ 123,790 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-04-04$49.17/sh−40,951→ 237,835 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-04-04$9.28/sh+40,951→ 278,786 total
Tax Payment
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-18$38.14/sh−12,687→ 237,835 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-04+65,000→ 250,522 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2024-03-04+240,000→ 240,000 total
Gift
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-02-12+20,000→ 110,000 total
Gift
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-02-12+20,000→ 110,000 total
Gift
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-02-12−60,000→ 570,805 total
Gift
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-02-12+20,000→ 110,000 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Incentive stock option (Right to Buy)
2023-11-09−50,000→ 101,270 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-11-09$1.91/sh+50,000→ 185,522 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-11-03$30.56/sh−199,082→ 135,522 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Non-qualified stock option (Right to Buy)
2023-11-03−199,082→ 164,741 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-11-03$9.28/sh+199,082→ 334,604 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Non-qualified stock option (Right to Buy)
2023-11-02−918→ 363,823 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-11-02$29.95/sh−918→ 135,522 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-11-02$9.28/sh+918→ 136,440 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-08-14$1.91/sh+10,000→ 135,522 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Incentve stock option (Right to Buy)
2023-08-14−10,000→ 151,270 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-07-13$20.35/sh−14,157→ 630,805 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-07-12$20.17/sh−11,459→ 644,962 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-07-11$20.14/sh−24,384→ 656,421 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-06-16$20.81/sh−50,000→ 680,805 total
Tax Payment
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-03-16$17.12/sh−4,628→ 125,522 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock (right to buy)
2023-03-01+287,700→ 287,700 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-03-01+61,650→ 130,150 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-10-12$1.91/sh+11,100→ 68,500 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Incentive stock option (Right to Buy)
2022-10-12−11,100→ 161,270 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-04-13$27.53/sh−69,176→ 730,805 total

Companies

Crinetics Pharmaceuticals, Inc.
Director, President & CEO
$CRNX

Recent Filings

Address

C/O CRINETICS PHARMACEUTICALS, INC. 6055 LUSK BOULEVARD

SAN DIEGO, CA, 92121

View on SEC.gov